ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
지질 나노입자 시장 규모는 향후 수년간 급성장이 전망됩니다. 2029년에는 CAGR 15.6%로 21억 6,000만 달러로 성장합니다. 예측 기간의 성장은 만성질환의 유병률 증가, RNA 기반 치료제에 대한 수요 증가, 첨단 유전자 도입 시스템에 대한 수요 증가, 맞춤형 의료에 대한 관심 증가, 연구개발에 대한 투자 증가에 기인합니다. 예측 기간의 주요 동향으로는 약물전달 기술의 발전, 혁신적인 약물전달 시스템, LNP 개발에 인공지능의 통합 등을 들 수 있습니다.
향후 5년간 15.6%의 성장률 전망은 지난번 예측보다 0.7% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 장벽은 스위스나 한국에서 조달하는 mRNA 백신 인캡슐레이션 재료의 비용을 상승시킴으로써 미국의 약물전달 기술 혁신을 저해하고, 신규 치료제 개발 지연 및 바이오 제조 비용 상승을 초래할 것으로 예측됩니다. 또한 상호 관세와 무역 마찰 및 제한 강화로 인한 세계 경제 및 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.
만성질환의 유병률 증가는 지질나노입자(LNPs) 시장 확대에 박차를 가하고 있습니다. 만성질환은 보통 3개월 이상 지속되는 장기적인 증상으로 당뇨병, 고혈압 등의 질병이 포함됩니다. 건강에 해로운 생활습관, 인구 고령화, 담배 사용, 영양 부족, 운동 부족, 과도한 알코올 섭취 등의 요인으로 인해 만성질환의 비율이 증가하고 있습니다. 지질나노입자(LNPs)는 mRNA 치료제나 백신의 효능을 높여 만성질환 관리에 효과적인 솔루션을 제시합니다. LNP는 만성질환의 치료 상황을 바꾸고, 관리 옵션을 개선하며, 환자에게 더 나은 결과를 가져올 수 있습니다. 예를 들어 영국 정부 기관인 국민보건서비스(NHS)에 따르면 2024년 6월 영국에서는 2023년 50만 명(54만 9,000명) 이상이 2형 당뇨병에 걸릴 위험이 있는 것으로 확인되었습니다. 이에 따라 GP에 등록된 비당뇨병성 고혈당 또는 당뇨병 예비 환자 수는 총 361만 5,330명으로 2022년 306만 5,825명에서 20% 가까이 증가했습니다. 이처럼 만성질환 유병률 증가는 지질 나노입자 시장의 성장을 가속하고 있습니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 지질 나노입자 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 용도 산업의 분석
세계의 지질 나노입자 시장 : 성장률 분석
세계의 지질 나노입자 시장 실적 : 규모와 성장, 2019-2024년
세계의 지질 나노입자 시장 예측 : 규모와 성장, 2024-2029년, 2034년
세계의 지질 나노입자 : TAM(Total Addressable Market)
제6장 시장 세분화
세계의 지질 나노입자 시장 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
나노 구조 지질 캐리어(NLC)
고체 지질 나노입자(SLN)
기타 유형
세계의 지질 나노입자 시장 : 용도별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
연구
치료제
세계의 지질 나노입자 시장 : 최종사용자별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
제약·바이오테크놀러지 기업
학술연구 센터
기타 최종사용자
세계의 지질 나노입자 시장 : 서브 세분화 나노 구조 지질 캐리어(NLC), 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
하드 NLC
소프트 NLC
세계의 지질 나노입자 시장 : 서브 세분화 고체 지질 나노입자(SLN), 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
기존형 SLN
수식 SLN
세계의 지질 나노입자 시장 : 서브 세분화 기타 유형(유형별), 실적과 예측, 2019-2024년, 2024-2029년, 2034년
지질 코어 미셀
리포솜
제7장 지역별·국가별 분석
세계의 지질 나노입자 시장 : 지역별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
세계의 지질 나노입자 시장 : 국가별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
지질 나노입자 시장 : 경쟁 구도
지질 나노입자 시장 : 기업 개요
Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
Bayer AG Overview, Products and Services, Strategy and Financial Analysis
Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
Amgen Inc.
The Merck Group
Evonik Industries AG
BioNTech SE
Moderna Inc.
Sanofi SA
Solid Biosciences Inc.
AstraZeneca PLC
NOF Corporation
Alnylam Pharmaceuticals Inc.
Nanomerics Ltd.
CordenPharma International
Nippon Fine Chemical
Helix Biotech Inc.
Dicerna Pharmaceuticals
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
지질 나노입자 시장 2029년 : 새로운 기회를 제공하는 국가
지질 나노입자 시장 2029년 : 새로운 기회를 제공하는 부문
지질 나노입자 시장 2029년 : 성장 전략
시장 동향에 기반한 전략
경쟁사 전략
제36장 부록
KSA
영문 목차
영문목차
Lipid nanoparticles are a class of nanoparticles primarily composed of lipids, essential fatty substances integral to cell membranes. These nanoparticles typically consist of a lipid bilayer or solid lipid matrix, characterized by their small size, typically ranging from 10 to 1000 nanometers in diameter.
The primary types of lipid nanoparticles include nanostructured lipid carriers (NLCs), solid lipid nanoparticles (SLNs), and other variations. Nanostructured lipid carriers (NLCs) are small structures composed of fats capable of encapsulating drugs or nutrients. They find applications in various fields including research and therapeutics and are utilized by diverse end-users such as pharmaceutical and biotechnology companies, academic and research institutions, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The lipid nanoparticles market research report is one of a series of new reports from The Business Research Company that provides lipid nanoparticles market statistics, including lipid nanoparticles industry global market size, regional shares, competitors with a lipid nanoparticles market share, detailed lipid nanoparticles market segments, market trends, and opportunities, and any further data you may need to thrive in the lipid nanoparticles industry. This lipid nanoparticles market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The lipid nanoparticles market size has grown rapidly in recent years. It will grow from $1.04 billion in 2024 to $1.21 billion in 2025 at a compound annual growth rate (CAGR) of 17.0%. The growth in the historic period can be attributed to rising focus on the development of LNP-based drugs, strong investment in research infrastructure, increasing healthcare expenditures.
The lipid nanoparticles market size is expected to see rapid growth in the next few years. It will grow to $2.16 billion in 2029 at a compound annual growth rate (CAGR) of 15.6%. The growth in the forecast period can be attributed to rising prevalence of chronic diseases, increasing demand for RNA-based therapeutics, increasing demand for advanced gene delivery systems, this increasing focus on personalized medicine, increasing investment in research and development. Major trends in the forecast period include advancements in drug delivery technologies, innovative drug delivery systems, integration of artificial intelligence in LNP development.
The forecast of 15.6% growth over the next five years reflects a modest reduction of 0.7% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. drug delivery innovation by increasing the cost of mRNA vaccine encapsulation materials sourced from Switzerland and South Korea, thereby delaying novel therapeutic development and elevating biomanufacturing costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The growing prevalence of chronic diseases is fueling the expansion of the lipid nanoparticles (LNPs) market. Chronic diseases are long-term conditions lasting typically over three months and include illnesses such as diabetes and hypertension. The rates of chronic diseases are increasing due to factors such as unhealthy lifestyle choices, aging populations, tobacco use, poor nutrition, physical inactivity, and excessive alcohol consumption. Lipid nanoparticles (LNPs) present a viable solution in managing chronic diseases by enhancing the efficacy of mRNA therapeutics and vaccines. They are transforming the treatment landscape for chronic conditions, offering improved management options and potentially better outcomes for patients. For instance, according to the National Health Service (NHS), a UK government department, in June 2024, over half a million (549,000) additional individuals in England were identified in 2023 as at risk of developing type 2 diabetes. This raised the total number of individuals with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330-a nearly 20% increase from 3,065,825 in 2022. Thus, the rising incidence of chronic diseases is driving growth in the lipid nanoparticle market.
Key players in the lipid nanoparticles market are spearheading innovations in circular RNA (circRNA) and lipid nanoparticle (LNP) formulations to gain a competitive advantage. The advancement of circular RNA (circRNA) and lipid nanoparticle (LNP) formulations expands the repertoire of RNA formats, including circRNA, a single-stranded RNA characterized by a covalently closed loop structure. For instance, in September 2023, GenScript Biotech, a prominent US-based life sciences company, augmented its reagent services to encompass circular RNA (circRNA) and lipid nanoparticles (LNP) formulation. These enhanced services align with GenScript's commitment to providing protein replacement therapies, gene and cell therapy solutions, and are readily available as part of the company's contract-manufactured reagent services. CircRNA offers several advantages over traditional linear RNA, including heightened stability, slower degradation, and the potential to achieve therapeutic protein levels at lower dosages.
In February 2022, Merck & Co., Inc., a leading US-based pharmaceutical company, completed the acquisition of Exelead for $780 million in cash. This strategic acquisition bolsters Merck's Life Science division by enabling the provision of comprehensive contract development and manufacturing organization (CDMO) services across the mRNA value chain. Exelead, a reputable US-based biopharmaceutical CDMO, specializes in the production of PEGylated products and complex injectable formulations, including lipid nanoparticle (LNP) based drug delivery technology, augmenting Merck's capabilities in advancing innovative therapies for chronic diseases.
Major companies operating in the lipid nanoparticles (LNPs) market report are Pfizer Inc.; Johnson & Johnson; AbbVie Inc.; Bayer AG; Abbott Laboratories; Amgen Inc; The Merck Group; Evonik Industries AG; BioNTech SE; Moderna Inc.; Sanofi SA; Solid Biosciences Inc.; AstraZeneca PLC; NOF Corporation; Alnylam Pharmaceuticals Inc.; Nanomerics Ltd.; CordenPharma International; Nippon Fine Chemical; Helix Biotech Inc.; Dicerna Pharmaceuticals; Gattefosse SAS; Arbutus Biopharma; Avanti Polar Lipids; IOI Oleo GmbH; Evox Therapeutics Ltd.
North America was the largest region in the lipid nanoparticles market in 2024. The regions covered in the lipid nanoparticles market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the lipid nanoparticles market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The lipid nanoparticles market consists of sales of solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs), and lipid-based nanoparticles (LBNPs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Lipid Nanoparticles Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on lipid nanoparticles market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for lipid nanoparticles ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The lipid nanoparticles market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Nano-Structured Lipid Carriers (NLCs); Solid Lipid Nanoparticles (SLNs); Other Types
2) By Application: Research; Therapeutics
3) By End User: Pharmaceutical And Biotechnology Companies; Academics And Research Centers; Other End Users
Subsegments:
1) By Nano-Structured Lipid Carriers (NLCs): Hard NLCs; Soft NLCs
2) By Solid Lipid Nanoparticles (SLNs): Conventional SLNs; Modified SLNs
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Lipid Nanoparticles Market Characteristics
3. Lipid Nanoparticles Market Trends And Strategies
4. Lipid Nanoparticles Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Lipid Nanoparticles Growth Analysis And Strategic Analysis Framework
5.1. Global Lipid Nanoparticles PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Lipid Nanoparticles Market Growth Rate Analysis
5.4. Global Lipid Nanoparticles Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Lipid Nanoparticles Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Lipid Nanoparticles Total Addressable Market (TAM)
6. Lipid Nanoparticles Market Segmentation
6.1. Global Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nano-Structured Lipid Carriers (NLCs)
Solid Lipid Nanoparticles (SLNs)
Other Types
6.2. Global Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Research
Therapeutics
6.3. Global Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceutical And Biotechnology Companies
Academics And Research Centers
Other End Users
6.4. Global Lipid Nanoparticles Market, Sub-Segmentation Of Nano-Structured Lipid Carriers (NLCs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hard NLCs
Soft NLCs
6.5. Global Lipid Nanoparticles Market, Sub-Segmentation Of Solid Lipid Nanoparticles (SLNs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Conventional SLNs
Modified SLNs
6.6. Global Lipid Nanoparticles Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Lipid-Core Micelles
Liposomes
7. Lipid Nanoparticles Market Regional And Country Analysis
7.1. Global Lipid Nanoparticles Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Lipid Nanoparticles Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
